Insider Selling: Nature's Sunshine Products, Inc. (NASDAQ:NATR) EVP Sells 9,996 Shares of Stock

Key Points

• Executive Vice President Nathan G. Brower sold 9,996 shares of Nature's Sunshine Products at an average price of $16.54, totaling approximately $165,333, which decreased his ownership by 17.15%.
• Nature's Sunshine Products reported $0.35 earnings per share for the previous quarter, exceeding analysts' expectations, with revenues of $114.75 million.
• Brokerages have set new target prices for NATR, with Canaccord Genuity increasing theirs from $21.00 to $22.00 and maintaining a "buy" rating.

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Nathan G. Brower sold 9,996 shares of the stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total transaction of $165,333.84. Following the completion of the transaction, the executive vice president directly owned 48,277 shares in the company, valued at approximately $798,501.58. This represents a 17.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Nature's Sunshine Products Stock Performance

NASDAQ NATR traded down $0.04 during mid-day trading on Friday, reaching $16.54. 35,925 shares of the stock were exchanged, compared to its average volume of 61,688. The company has a market capitalization of $291.84 million, a P/E ratio of 22.28 and a beta of 1.14. Nature's Sunshine Products, Inc. has a 1 year low of $11.01 and a 1 year high of $18.06. The business's 50 day moving average is $15.10 and its 200-day moving average is $14.03.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.19. The company had revenue of $114.75 million during the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%.

Analysts Set New Price Targets

A number of brokerages have weighed in on NATR. DA Davidson restated a "buy" rating and issued a $19.00 target price on shares of Nature's Sunshine Products in a research report on Tuesday, June 3rd. Canaccord Genuity Group boosted their target price on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a research note on Friday, August 1st.

Hedge Funds Weigh In On Nature's Sunshine Products

Several large investors have recently added to or reduced their stakes in NATR. GAMMA Investing LLC grew its holdings in Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock worth $28,000 after acquiring an additional 2,132 shares during the period. MTM Investment Management LLC acquired a new stake in shares of Nature's Sunshine Products during the 2nd quarter valued at about $30,000. Raymond James Financial Inc. acquired a new stake in shares of Nature's Sunshine Products during the 2nd quarter valued at about $37,000. Russell Investments Group Ltd. acquired a new stake in Nature's Sunshine Products in the 4th quarter worth approximately $41,000. Finally, Deutsche Bank AG bought a new position in Nature's Sunshine Products in the 4th quarter worth approximately $103,000. 79.40% of the stock is currently owned by institutional investors.

Nature's Sunshine Products Company Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.